Ultragenyx Pharmaceutical (RARE) EBT Margin Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2,817.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,558.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -683.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,688.00 |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | -2,738.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,738.00 |
| Dec 31, 2025 | -32,288.00 |
| Sep 30, 2025 | -1,676.00 |
| Jun 30, 2025 | 2,045.00 |
| Mar 31, 2025 | 4,850.00 |
| Dec 31, 2024 | 36,150.00 |
| Sep 30, 2024 | 6,666.00 |
| Jun 30, 2024 | 5,797.00 |
| Mar 31, 2024 | 626.00 |
| Dec 31, 2023 | 4,809.00 |
| Sep 30, 2023 | 10,114.00 |
| Jun 30, 2023 | 2,980.00 |
| Mar 31, 2023 | 2,719.00 |
| Dec 31, 2022 | 131.00 |
| Sep 30, 2022 | -17,411.00 |
| Jun 30, 2022 | -3,646.00 |
| Mar 31, 2022 | -5,327.00 |
| Dec 31, 2021 | -12,347.00 |
| Sep 30, 2021 | -506.00 |
| Jun 30, 2021 | -18,193.00 |
| Mar 31, 2021 | 19,010.00 |
| Dec 31, 2020 | 23,020.00 |
| Sep 30, 2020 | 35,271.00 |
| Jun 30, 2020 | 45,148.00 |
| Mar 31, 2020 | 20,457.00 |
| Dec 31, 2019 | 28,297.00 |
| Sep 30, 2019 | 30,332.00 |
| Jun 30, 2019 | 155.00 |
| Mar 31, 2019 | -81,497.00 |
| Dec 31, 2018 | 412,486.00 |
| Sep 30, 2018 | 3.93 Mn |
| Dec 31, 2017 | 142.04 Mn |
| Sep 30, 2017 | 1.85 Mn |